Declines in patient visits during COVID-19 shutdowns projected to cost U.S. primary care $15 billion in revenue by year’s end, study shows

Harvard Medical School
24-Jun-2020 10:00 AM EDT, by Harvard Medical School

Newswise — Primary care practices are projected to lose more than $65,000 in revenue per full-time physician in 2020, following drastic declines in office visits and fees for services from March to May during the COVID-19 pandemic, according to a study led by researchers in the Blavatnik Institute at Harvard Medical School.

The lost revenue adds up to a shortfall of $15 billion to primary care practices across the United States, according to the analysis published June 25 in Health Affairs.

The researchers caution that losses would balloon substantially if there is a second viral peak later in the year or if the reimbursement rates for telehealth visits revert to pre-COVID levels.

The study was led by Sanjay Basu,  director of research and population health at Collective Health and a faculty affiliate in the HMS Center for Primary Care, Russell Phillips, director of the center and professor of global health and social medicine at HMS, and Bruce Landon, HMS professor of health care policy. 

“For many primary care practices, particularly those serving the most vulnerable populations, these losses could be catastrophic, with many practices being forced to close,” Basu said.  “This could weaken the U.S. health system dramatically at a time when we need it to be at its strongest.”

“ Our prior work shows that primary care saves lives, and loss of primary care practices will translate to lives lost across the United States,” Phillips said. 

To calculate the projected financial losses on operating expenses and revenues, the researchers simulated the impact of the pandemic on a variety of practices analyzing both visit volume and visit type, among other variables. They then compared the anticipated revenues, expenses and losses under several scenarios, including a second shelter-in-place order in November and December as well as reverting back to the significantly lower prepandemic levels of provider reimbursement for telemedicine visits.

Once the most acute threat of COVID-19 subsides and the pandemic winds down, primary care in the United States will have to absorb the brunt of long-term COVID-19 care and management, testing and vaccination, the team said. The primary care system must also be equipped to meet the piled-up needs of the population and return its attention to the major chronic medical conditions that collectively will determine the health of Americans for many years to come, they said.

“The coronavirus pandemic highlights the fragility of the primary care system,” said Landon, noting that “over half of primary care practices remain small and physician-owned and these independent practices have limited access to capital and other support that could help them weather the pandemic.”  

The researchers said their findings and the looming growth in primary care use underscores the need for a financial boost to the primary care system.

“The coronavirus pandemic is a pointed reminder of the importance of primary care to our society. Primary care is critical to limiting the spread of the virus, in treating the comorbidities that can make COVID-19 so deadly and in helping people navigate the social and psychological challenges of social distancing and of living with the pandemic,” Phillips said.

While legislation proposing financial aid to hospitals has already been introduced in Congress, independent primary care practices have yet to receive significant financial help, the researchers said.

Additional collaborators on the study include colleagues from the American Board of Family Medicine.

The authors report no external funding for this study.

DOI: 10.1377/hlthaff.2020.00794


Filters close

Showing results

110 of 3477
Newswise: 2?ui=2&ik=4c9feb129e&attid=0.1.2&permmsgid=msg-f:1679265798511464405&th=174df358bbbd0fd5&view=att&disp=emb&realattid=d6762a918b647b2ba204268693b0cd89
30-Sep-2020 10:20 AM EDT
Influence of bots on spreading vaccine information not as big as you think
University of Sydney

The role of bots in spreading vaccine-critical information on Twitter is limited, and rarely cross paths with active Twitter users, finds study led by University of Sydney.

Newswise: Vaccine Opposition Online Uniting Around ‘Civil Liberties’ Argument
1-Oct-2020 10:40 AM EDT
Vaccine Opposition Online Uniting Around ‘Civil Liberties’ Argument
George Washington University

Anti-vaccination discourse on Facebook increased in volume over the last decade, coalescing around the argument that refusing to vaccinate is a civil right, according to a study published today in the American Journal of Public Health.

Released: 1-Oct-2020 3:50 PM EDT
COVID-19 infects majority of bad dreams -- study

COVID-19 has turned 2020 into a nightmare for many people, as they struggle with health problems, economic uncertainty and other challenges.

Newswise: UC San Diego Health Joins International Clinical Trial to Test Coronavirus Vaccine
Released: 1-Oct-2020 3:35 PM EDT
UC San Diego Health Joins International Clinical Trial to Test Coronavirus Vaccine
University of California San Diego Health

UC San Diego Health will be a test site for a third, major Phase III clinical trial to assess a vaccine candidate for the novel coronavirus that causes COVID-19. Sponsored by Janssen Pharmaceuticals, the trial will recruit up to 60,000 participants at sites in the United States and worldwide.

Released: 1-Oct-2020 2:50 PM EDT
UC San Diego Partners with San Ysidro Health to Expand COVID-19 Testing
University of California San Diego Health

Researchers at University of California San Diego School of Medicine, in collaboration with local partners, have been awarded a $5 million grant from the National Institutes of Health (NIH) to implement a program of widespread testing for COVID-19 in San Ysidro, focused on pregnant women and children.

Newswise: Promising COVID-19 Rapid Test Technology Enters Phase 1 of NIH Challenge
Released: 1-Oct-2020 2:25 PM EDT
Promising COVID-19 Rapid Test Technology Enters Phase 1 of NIH Challenge
Columbia University School of Engineering and Applied Science

A promising new COVID-19 rapid-testing technology platform developed by Rover Diagnostics and Columbia Engineering has been selected by the NIH to enter Phase 1 of the RADx initiative to support new COVID-19 testing technologies. The affordable, portable, and ultrafast point-of-care Rover platform provides reverse transcription polymerase chain reaction results in eight minutes, faster than any other test of its kind, with targeted accuracy to match laboratory-based tests.

30-Sep-2020 10:30 AM EDT
Researchers call for loss of smell to be recognized globally as a symptom of COVID-19

Four out of five people experiencing the recent loss of smell and/or taste tested positive for COVID-19 antibodies—and of those who tested positive, 40 percent did not have cough or fever, reports a new study in PLOS Medicine by Prof. Rachel Batterham at University College London and colleagues.

Released: 1-Oct-2020 1:35 PM EDT
COVID vs. Flu vs. Common Cold: What You Need to Know
Children's Hospital Los Angeles

With cold and flu season underway, plus the ongoing COVID-19 pandemic, infectious disease specialist Jeffrey Bender, MD, shares how to tell the difference between the three illnesses, and the most important thing parents can do to keep children safe.

Newswise: Carter-Butts-768x615.png
Released: 1-Oct-2020 1:20 PM EDT
Population distribution can greatly impact COVID-19 spread, UCI-led study finds
University of California, Irvine

Irvine, Calif., Oct. 1, 2020 — Uneven population distribution can significantly impact the severity and timing of COVID-19 infections within a city or county, leading individual communities to have vastly different experiences with the pandemic, according to a recent study led by the University of California, Irvine. Findings published in Proceedings of the National Academy of Sciences show that the heterogeneous spatial features of interpersonal connections may produce dramatic local variations in exposures to those with the illness.

Released: 1-Oct-2020 1:15 PM EDT
Arizona State University researchers awarded $4.7M by NIH to expand COVID-19 testing in underserved Arizona communities
Arizona State University (ASU)

In Arizona, as in other parts of the country, data shows that COVID-19 has disproportionately affected the American Indian, African American and Latinx communities, as well as other vulnerable populations. A $4.7 million grant from the National Institute of Health to ASU’s Southwest Interdisciplinary Research Center (SIRC) is on the way to help address this by funding a rapid and large-scale increase in COVID-19 testing of underserved communities across Arizona.

Showing results

110 of 3477